Four patients had objective (partial) response, and all of these had received the 10 mg/ kg dose bevacizumab; the ORR for the 10 mg/ kg dose was 10%.
Neljal patsiendil oli objektiivne (osaline) ravivastus ning kõik need patsiendid olid saanud bevatsizumabi annuses 10 mg/ kg; üldine ravivastuse sagedus oli 10 mg/ kg annuse puhul 10%.